ArticleJMIR infodemiology2025
Global Surveillance of Public Interest in Cosmetic Tourism for Aesthetic Eyelid Surgery Abroad: Cross-Sectional Infodemiology Investigation of Internet Search Trends and Social Media Content.
Article in JMIR infodemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Global medical tourism for aesthetic surgery has become a popular phenomenon through ease of access in the digital era, though such services are not without potential risks. The application of infodemiology for global health surveillance may provide unique insights into unknown patient travel patterns and surgeon workforce dynamics abroad. Objective: This study aimed to evaluate American cosmetic tourism trends in oculofacial plastic surgery, including demand profile and qualifications of the most sought-after international eyelid surgeons on social media. Methods: This cross-sectional infodemiology study queried Google Trends to assess US interests in aesthetic eyelid surgery abroad in 25 destination countries from 2013 to 2023. The highest-rated content posted by 55 eyelid surgeons (US: n=11; international: n=44) on a social media platform (Instagram; Meta Platforms) was evaluated. The main outcomes included Google search volumes for aesthetic eyelid surgery for each destination country, as well as specialty training and professional medical society affiliations of popular eyelid surgeons on social media in each of these countries. Results: The top 5 destinations Americans sought for aesthetic eyelid surgery abroad were South Korea, Mexico, Canada, Turkey, and China. Interest in eyelid surgery abroad remained stable over the last decade despite 118% growth in blepharoplasty searches. Social media indicated eyelid surgeons abroad were more often general plastic surgeons than in the United States (30/44, 68% vs 2/11, 18%; P=.003). US surgeons more frequently completed oculofacial plastics, facial plastics, or aesthetic plastics fellowships compared with international surgeons (9/11, 82% vs 10/44, 23%; P<.001) and had membership in professional medical societies (11/11, 100% vs 22/44, 50%; P=.002). Conclusions: American demand for international eyelid surgery remained stable over the past decade despite a 2-fold increase in the US interest for blepharoplasty. Digital epidemiology data reveal a shortage of international surgeons with specialized aesthetic eyelid fellowship training or professional society affiliations on social media among the preferred destinations for Americans seeking aesthetic eyelid surgery. These findings may provide beneficial insights for patients interested in traveling abroad for eyelid surgery, as well as for surgeons or academic societies seeking to increase social media presence or patient-directed educational content via social media engagement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.